Close Menu

NEW YORK — Novacyt on Monday reported a 906 percent year-over-year increase in unaudited revenues for the first half of 2020, driven by strong demand for COVID-19 testing.

For the six months ended 30 June, the Paris-based company reported unaudited revenues of €72.4 million ($82 million) compared to €7.2 million for the first half of 2019. The firm said it booked 91 percent of the revenues in the second quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.